PXT00864
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PXT00864, covering 2016-02-15 to 2016-02-15. Get the full timeline:
Most recent: Clinical Trial Update: 24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion [Phase 2]